Dow rallies 300 points on positive vaccine-trial data, blockbuster Goldman earnings

Business Insider

Published

· *US stocks rose Wednesday after drugmaker Moderna announced an early coronavirus vaccine trial produced antibodies in all participants.*
· *Major indexes were also lifted by strong quarterly earnings from Goldman Sachs, which saw the firm handily beat analyst profit estimates.*
· *The so-called reopening trade gained,...

Full Article